IP Library › Granted Patent US 10,640,818
Granted Patent B2
US 10,640,818 · App. 15/353,595 · Granted May 5, 2020

Compositions and methods for selection of nucleic acids

Inventors: Thang Tat Pham (Mountain View, CA); Yu-Chih Tsai (Fremont, CA); Jonas Korlach (Camas, WA); Tyson A. Clark (Menlo Park, CA); Stephen Turner (Seattle, WA)
Assignee: Pacific Biosciences of California, Inc.
C12Q1/6855C12N15/1072C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,640,818
App. No.
15/353,595
Granted
May 5, 2020
Kind
B2
Abstract

Methods are provided for reducing the complexity of a population of nucleic acids prior to performing an analysis of the nucleic acids, e.g., sequence analysis. The methods result in a subset of the initial population enriched for a target region, which is typically located within one or more target fragments. The methods are particularly useful for analyzing populations having a high degree of complexity, e.g., chromosomal-derived DNA, whole genomic DNA, or mRNA populations.

Claims (24)

1. A method for enrichment of a target region in a nucleic acid sample comprising:

a) obtaining a nucleic acid sample comprising a mixture of double-stranded nucleic acid fragments, wherein a subset of fragments in the mixture comprises the target region;

b) digesting the nucleic acid sample with a first endonuclease and a second endonuclease to produce a population of double-stranded nucleic acid fragments, wherein the first endonuclease cleaves a particular nucleotide sequence that is upstream of the target region and the second endonuclease cleaves a particular nucleotide sequence that is downstream of the target region;

c) ligating stem-loop adapters to the population of double-stranded nucleic acid fragments to produce a ligated sample; and

d) treating the ligated sample with: (i) one or more third endonucleases that do not cleave stem-loop ligated double-stranded nucleic acid fragments that include the target region, and (ii) one or more exonucleases that digest double-stranded nucleic acid fragments cleaved by the one or more third endonucleases, having one stem-loop adapter ligated thereto, or having no stem-loop adapter ligated thereto, thereby enriching for the target region in the nucleic acid sample.

2. The method of claim 1 , wherein a primer binding sequence is present within the stem-loop adapter.

3. The method of claim 2 , further comprising hybridizing a primer to the primer binding sequence in the enriched double-stranded nucleic acid fragments and exposing the primer-hybridized double-stranded nucleic acid fragments to a polymerase enzyme to generate a polymerase complex.

4. The method of claim 3 , further comprising exposing the polymerase complex to a capture-hook oligonucleotide attached to a magnetic bead to selectively capture the polymerase complex.

5. The method of claim 4 , wherein the capture-hook oligonucleotide only captures an active polymerase complex by binding to a region of the nucleic acid in the polymerase complex that has been rendered single-stranded by the polymerase enzyme.

6. The method of claim 1 , further comprising performing template-directed sequencing-by-synthesis on the enriched nucleic acid fragments.

7. The method of claim 6 , wherein the template-directed sequencing-by-synthesis generates redundant sequence information from single molecules of the enriched nucleic acid fragments.

8. The method of claim 1 , further comprising isolating fragments having an approximate size of a double-stranded nucleic acid fragment comprising the target region generated by digestion with the first endonuclease and a second endonuclease prior to the ligating step.

9. The method of claim 1 , wherein the first endonuclease and the second endonuclease are selected from the group consisting of: a type II restriction endonuclease, a type IIs restriction endonuclease, an engineered endonuclease, and any combination thereof.

10. The method of claim 9 , wherein the engineered endonuclease is an engineered zinc finger DNA-binding protein endonuclease.

11. The method of claim 9 , wherein the first endonuclease and the second endonuclease are engineered endonucleases.

12. The method of claim 1 , wherein the first endonuclease, the second endonuclease, or both leave ends with single-stranded overhangs.

13. The method of claim 12 , wherein:

the first endonuclease leaves a first single-stranded overhang and the second endonuclease leaves a second single-stranded overhang, wherein the first single-stranded overhang and the second single-stranded overhang are different; and

the stem-loop adapters comprise first stem-loop adapters and second stem-loop adapters, wherein the first stem-loop adapters comprise a single-stranded overhang that is complementary to the first single-stranded overhang and the second stem-loop adapters comprise a single-stranded overhang that is complementary to the second single-stranded overhang.

14. The method of claim 1 , wherein the first endonuclease, the second endonuclease, or both leave blunt ends.

15. The method of claim 1 , wherein the target region comprises repetitive sequences.

16. The method of claim 15 , wherein the repetitive sequences are repeat sequences associated with a genetic disorder.

17. The method of claim 16 , wherein the genetic disorder is selected from the group consisting of: fragile X syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Parkinson's disease, autism, cancer, myotonic dystrophy, ataxia, epilepsy, and Huntington's disease.

18. The method of claim 1 , wherein multiple different target regions are enriched in the nucleic acid sample.

Continuity (4)
Continuation 14069067 · Oct 31, 2013
Provisional Application 61789354 · Mar 15, 2013
Provisional Application 61721339 · Nov 1, 2012
Related Publication 20170145492A1 · May 25, 2017
Cited By (2)
US 12,227,801 US 12,252,742